Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2022-11-04 00:00:00 ET · period of report 2022-11-02 · accession 0001654954-22-014746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-11-04 | 2022-11-02 | EDSA | NIFFENEGGER KATHI | CFO | A - Grant | $1.13 | +8,888 | 10.7K | +486% | +$10.0K |
| DMI | 2022-11-04 | 2022-11-02 | EDSA | NIFFENEGGER KATHI | CFO | A - Grant | — | +8,888 | 4,444 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-11-02 | A | A | 8,888 | $1.13 | 10,715 | I By Trust | — | — | (F1) The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. |
| 2 | Derivative | Common Share Warrants (Right to Buy) | 2022-11-02 | A | A | 4,444 | — | 4,444 | I By Trust | $1.50 · — to — | 4,444 Common Shares | (F2) Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. (F1) The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. |
| 3 | Derivative | Common Share Warrants (Right to Buy) | 2022-11-02 | A | A | 4,444 | — | 4,444 | I By Trust | $1.00 · — to — | 4,444 Common Shares | (F3) Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. (F1) The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. |